•The first issue is to exclude and prevent any cause of rebleeding. •In patients without a bleeding source, several treatements have been proposed: iron chelation, CSF shunting and heme oxygenase inhibitors. These therapies may arrest the progression of the disease, but their efficacy is disputed.